Yang Arvin 4
4 · Mersana Therapeutics, Inc. · Filed Dec 2, 2020
Insider Transaction Report
Form 4
Yang Arvin
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-11-30+200,000→ 200,000 totalExercise: $25.48Exp: 2030-11-29→ Common Stock (200,000 underlying) - Award
Restricted stock unit
2020-11-30+37,000→ 37,000 totalExp: 2030-11-29→ Common Stock (37,000 underlying)
Footnotes (3)
- [F1]The options will vest as to 25% of the shares on the first anniversary of the grant date and in equal quarterly installments over the next three years.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon vesting.
- [F3]The restricted stock units will vest as to 50% of the shares on the first anniversary of the grant date and 50% of the shares on the second anniversary of the grant date.